Journal
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
Volume 23, Issue 1, Pages 54-56Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00043426-200101000-00013
Keywords
Langerhans cell histiocytosis; osteolytic lesions; analgesics; biphosphonates; pain
Categories
Ask authors/readers for more resources
A 14-year-old boy with longstanding multisystem Langerhans cell histiocytosis (LCH) had multifocal bone pain unresponsive to chemotherapy, corticosteroids, anti-inflammatories, and narcotic analgesics. He responded to two cycles of intravenous pamidronate, each 90 mg per day on three consecutive days. Two subsequent episodes of deterioration also responded to treatment. The pathophysiology of his bone pain and the likely mechanisms of biphosphonate action are discussed, with emphasis on the molecular and cellular basis of LCH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available